ONCO Onconetix, Inc.
Healthcare$1.24+1.64%ClosedMarket Cap: $414,196
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.07
P/S
0.56
EV/EBITDA
0.45
DCF Value
$1.40
FCF Yield
-2366.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
79.6%
Operating Margin
-922.7%
Net Margin
-1319.6%
ROE
-105.5%
ROA
-65.4%
ROIC
-56.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $21.5K | -7.7% | $-2.1M | $-4.2M | $— | — |
| Q4 null | $303.6K | 81.6% | $-1.3M | $5.7M | $— | — |
| FY null | $815.4K | 77.6% | $-6.3M | $-14.0M | $— | — |
| Q3 null | $303.7K | 88.6% | $-2.1M | $-8.8M | $— | — |
| Q2 null | $106.5K | 66.2% | $-1.3M | $-2.4M | $— | — |
| Q1 null | $101.6K | 45.1% | $-1.7M | $-8.5M | $— | — |
| Q4 null | $712.0K | 92.7% | $-29.1M | $-29.4M | $— | — |
| FY null | $2.5M | 41.8% | $-56.5M | $-58.7M | $— | — |
| Q3 null | $406.9K | 25.9% | $-2.6M | $-3.8M | $— | — |
| Q2 null | $704.8K | 14.3% | $-13.6M | $-14.3M | $— | — |
| Q1 null | $700.4K | 27.0% | $-11.1M | $-11.1M | $— | — |
| Q4 2023 | $58.5K | -1941.8% | $-5.4M | $-22.4M | $-0.29 | — |